6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Publication
, Conference
Kollins, SH; Cutler, AJ; Khattak, S; Weiss, MD; Donnelly, G; Reiz, JL
Published in: Journal of the American Academy of Child & Adolescent Psychiatry
October 2016
Duke Scholars
Published In
Journal of the American Academy of Child & Adolescent Psychiatry
DOI
ISSN
0890-8567
Publication Date
October 2016
Volume
55
Issue
10
Start / End Page
S217 / S218
Publisher
Elsevier BV
Related Subject Headings
- Developmental & Child Psychology
- 5201 Applied and developmental psychology
- 3213 Paediatrics
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kollins, S. H., Cutler, A. J., Khattak, S., Weiss, M. D., Donnelly, G., & Reiz, J. L. (2016). 6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER. In Journal of the American Academy of Child & Adolescent Psychiatry (Vol. 55, pp. S217–S218). Elsevier BV. https://doi.org/10.1016/j.jaac.2016.09.362
Kollins, Scott H., Andrew J. Cutler, Sohail Khattak, Margaret D. Weiss, Graeme Donnelly, and Joseph L. Reiz. “6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.” In Journal of the American Academy of Child & Adolescent Psychiatry, 55:S217–18. Elsevier BV, 2016. https://doi.org/10.1016/j.jaac.2016.09.362.
Kollins SH, Cutler AJ, Khattak S, Weiss MD, Donnelly G, Reiz JL. 6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER. In: Journal of the American Academy of Child & Adolescent Psychiatry. Elsevier BV; 2016. p. S217–8.
Kollins, Scott H., et al. “6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 55, no. 10, Elsevier BV, 2016, pp. S217–18. Crossref, doi:10.1016/j.jaac.2016.09.362.
Kollins SH, Cutler AJ, Khattak S, Weiss MD, Donnelly G, Reiz JL. 6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER. Journal of the American Academy of Child & Adolescent Psychiatry. Elsevier BV; 2016. p. S217–S218.
Published In
Journal of the American Academy of Child & Adolescent Psychiatry
DOI
ISSN
0890-8567
Publication Date
October 2016
Volume
55
Issue
10
Start / End Page
S217 / S218
Publisher
Elsevier BV
Related Subject Headings
- Developmental & Child Psychology
- 5201 Applied and developmental psychology
- 3213 Paediatrics
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences